Endocrine glands
Endocrine glands
Food and insulin release
Food and insulin release

Insulinoma

Definition:
A usually benigntumor of the insulin-secreting cells of the pancreas.

Alternative Names:
Insuloma; Islet cells adenoma

Causes, incidence, and risk factors:

The pancreas is an organ in the abdomen that releases the hormone insulin. Insulin is required to regulate blood levels of the sugar glucose. Tumors of the pancreas that produce excessive amounts of insulin (hyperinsulinemia) are called insulinomas.

High insulin levels cause hypoglycemia, or low blood glucose. Hypoglycemia caused by insulinomas may be mild and lead to symptoms such as anxiety and hunger, but patients are also at risk for severe hypoglycemia that can cause seizures, coma and even death.

Insulinomas are rare tumors that occur in about 1 out of 250,000 people. They usually occur as single, small tumors in adults, though the majority of children with hyperinsulinemia do not have a discrete tumor.

Five to ten percent of insulinomas are malignant. Patients diagnosed with multiple endocrine neoplasia, Type I (MENI), are at risk to develop insulinomas.

Symptoms:
Signs and tests:
  • during a monitored fast:
    • low blood glucose
    • high serum insulin level
    • high C-peptide level
  • CT scan or MRI of the abdomen to look for a pancreatic tumors
  • Octreotide scan to look for pancreatic tumors (when CT or MRI scan is unrevealing)
  • Pancreatic arteriography (when CT or MRI scan is unrevealing)
  • Pancreatic venous sampling for insulin (when CT or MRI scan is unrevealing)
Treatment:

Surgery is the preferred treatment for insulinoma. The tumor is localized with diagnostic testing or surgical exploration. Solitary tumors are resected, but patients with multiple tumors usually require partial resection of the pancreas (partial pancreatectomy). At least 15% of the pancreas is left to avoid malabsorption due to lack of pancreatic enzymes.

If no tumor is found at surgery or a patient is not a candidate for surgery, the drug diazoxide may be given to lower insulin secretion and avoid hypoglycemia. A diuretic is always given with this medication to avoid retaining too much salt. Medical treatment is also used to stabilize the person prior to surgery.

Expectations (prognosis):

Death may result from a severe hypoglycemic reaction or spread of malignant tumors to other organs (metastases).

Complications:
Calling your health care provider:

Call your health care provider if symptoms of insulinoma develop. Convulsions and decreased consciousness are emergency symptoms.

Prevention:

There is no known way to prevent the development of an insulinoma.


Review Date: 6/3/2001
Reviewed By: Michael Jakoby, M.D., M.A., Division of Atherosclerosis, Nutrition and Lipid Research, Washington University, St. Louis, MO. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.